BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35436040)

  • 1. Quantification of Early Diffuse Myocardial Fibrosis Through 7.0 T Cardiac Magnetic Resonance T1 Mapping in a Type 1 Diabetic Mellitus Mouse Model.
    Zhang H; Shi C; Yang L; Zhang N; Li G; Zhou Z; Gao Y; Liu D; Xu L; Fan Z
    J Magn Reson Imaging; 2023 Jan; 57(1):167-177. PubMed ID: 35436040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between myocardial extracellular volume and strain analysis through cardiovascular magnetic resonance with histological myocardial fibrosis in patients awaiting heart transplantation.
    Cui Y; Cao Y; Song J; Dong N; Kong X; Wang J; Yuan Y; Zhu X; Yan X; Greiser A; Shi H; Han P
    J Cardiovasc Magn Reson; 2018 Apr; 20(1):25. PubMed ID: 29681243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes in cardiac morphology, function, and diffuse myocardial fibrosis duration of diabetes in type 1 and type 2 diabetic mice models using 7.0 T CMR and echocardiography.
    Zhang HK; Shi CY; Liu DT; Gao HQ; Zhao QQ; Zhang N; Yang L; Li GQ; Wang YL; Du Y; Li Q; Bo KR; Zhuang B; Fan ZM; Sun ZH; Xu L
    Front Endocrinol (Lausanne); 2023; 14():1278619. PubMed ID: 38027188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of diffuse myocardial fibrosis using CMR extracellular volume fraction and serum biomarkers of collagen turnover with histologic quantification as standard of reference.
    Foussier C; Barral PA; Jerosh-Herold M; Gariboldi V; Rapacchi S; Gallon A; Bartoli A; Bentatou Z; Guye M; Bernard M; Jacquier A
    Diagn Interv Imaging; 2021 Mar; 102(3):163-169. PubMed ID: 32830084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial Native T
    Omori T; Nakamori S; Fujimoto N; Ishida M; Kitagawa K; Ichikawa Y; Kumagai N; Kurita T; Imanaka-Yoshida K; Hiroe M; Sakuma H; Ito M; Dohi K
    JACC Cardiovasc Imaging; 2020 Oct; 13(10):2117-2128. PubMed ID: 32771571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological validation of cardiac magnetic resonance T
    Zeng M; Zhang N; He Y; Wen Z; Wang Z; Zhao Y; Greiser A; An J; Zhang T; Jing B; Zhang X; Fan Z; Li D
    J Magn Reson Imaging; 2016 Nov; 44(5):1179-1185. PubMed ID: 27061226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients.
    Ide S; Riesenkampff E; Chiasson DA; Dipchand AI; Kantor PF; Chaturvedi RR; Yoo SJ; Grosse-Wortmann L
    J Cardiovasc Magn Reson; 2017 Feb; 19(1):10. PubMed ID: 28143545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.
    White SK; Sado DM; Fontana M; Banypersad SM; Maestrini V; Flett AS; Piechnik SK; Robson MD; Hausenloy DJ; Sheikh AM; Hawkins PN; Moon JC
    JACC Cardiovasc Imaging; 2013 Sep; 6(9):955-62. PubMed ID: 23582361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis.
    Gao Y; Wang HP; Liu MX; Gu H; Yuan XS; Biekan J; Wang XM
    Eur Radiol; 2023 Mar; 33(3):1982-1991. PubMed ID: 36241919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of diffuse myocardial fibrosis in rats using small-animal Look-Locker inversion recovery T1 mapping.
    Messroghli DR; Nordmeyer S; Dietrich T; Dirsch O; Kaschina E; Savvatis K; O h-Ici D; Klein C; Berger F; Kuehne T
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):636-40. PubMed ID: 21917782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMR-Derived Extracellular Volume Fraction as a Marker for Myocardial Fibrosis: The Importance of Coexisting Myocardial Inflammation.
    Lurz JA; Luecke C; Lang D; Besler C; Rommel KP; Klingel K; Kandolf R; Adams V; Schöne K; Hindricks G; Schuler G; Linke A; Thiele H; Gutberlet M; Lurz P
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):38-45. PubMed ID: 28412435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy.
    Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of doxorubicin-induced interstitial myocardial fibrosis in a beagle model using equilibrium contrast-enhanced computed tomography: A comparative study with cardiac magnetic resonance T1-mapping.
    Zhou Z; Xu L; Wang R; Varga-Szemes A; Durden JA; Joseph Schoepf U; Sun Z; Fan Z
    Int J Cardiol; 2019 Apr; 281():150-155. PubMed ID: 30738608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain.
    Cao Y; Zeng W; Cui Y; Kong X; Wang M; Yu J; Zhang S; Song J; Yan X; Greiser A; Shi H
    Cardiovasc Diabetol; 2018 Jan; 17(1):7. PubMed ID: 29301529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of Hepatic T1-Mapping and Extracellular Volume Quantification on Routine Cardiac Magnetic Resonance Imaging in Patients with Infiltrative and Systemic Disorders.
    Dolan RS; Stillman AE; Davarpanah AH
    Acad Radiol; 2022 Apr; 29 Suppl 4():S100-S109. PubMed ID: 34702675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
    Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial tissue characterization by contrast-enhanced cardiac magnetic resonance imaging in subjects with prediabetes, diabetes, and normal controls with preserved ejection fraction from the general population.
    Storz C; Hetterich H; Lorbeer R; Heber SD; Schafnitzel A; Patscheider H; Auweter S; Zitzelsberger T; Rathmann W; Nikolaou K; Reiser M; Schlett CL; von Knobelsdorff-Brenkenhoff F; Peters A; Schulz-Menger J; Bamberg F
    Eur Heart J Cardiovasc Imaging; 2018 Jun; 19(6):701-708. PubMed ID: 28950340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the cardiac magnetic resonance derived extracellular volume fraction and feature tracking myocardial strain in patients with non-ischemic dilated cardiomyopathy.
    Azuma M; Kato S; Kodama S; Hayakawa K; Kagimoto M; Iguchi K; Fukuoka M; Fukui K; Iwasawa T; Utsunomiya D; Kimura K; Tamura K
    Magn Reson Imaging; 2020 Dec; 74():14-20. PubMed ID: 32898651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.
    aus dem Siepen F; Buss SJ; Messroghli D; Andre F; Lossnitzer D; Seitz S; Keller M; Schnabel PA; Giannitsis E; Korosoglou G; Katus HA; Steen H
    Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):210-6. PubMed ID: 25246502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.